Tag Archives: Global Plan

Statement from EGPAF and m2m on WHO’s Option B+ Approach to Protect the Health of HIV-Positive Mothers and Their Babies

WASHINGTON, D.C. – July 27, 2012 – At the XIX International AIDS Conference in Washington, D.C., there has been growing global momentum around optimal approaches to prevent transmission of HIV from mother to child and to keep HIV-positive mothers alive and healthy.

The World Health Organization (WHO) recently encouraged countries to consider accelerating the adoption of one of two options for preventing mother-to-child transmission of HIV (PMTCT) that both include added benefits for and emphasis on the health of mothers. Option B includes the use of triple-drug therapy for the mother during pregnancy and breastfeeding, and Option B+ continues that drug regimen for the mother’s lifetime.

The WHO’s three options – Options A, B, and B+ – all afford similar protection against mother-to-child transmission of HIV, but Option B+ has the greatest potential for health benefits for infected women, and can confer protection against transmission of HIV to an uninfected partner.

There is growing consensus that Option B+ represents an evolving best standard for protecting both mother and child from the effects of HIV. The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and mothers2mothers (m2m) support the development and implementation of revised WHO technical and operational guidelines, and will assist the implementation of whichever option is chosen by national governments.

Adoption of Option B+ will require careful study of new and existing operational issues. EGPAF is prepared to use its considerable country presence, technical capacity, and research ability to investigate the operational issues that need to be addressed and understood for optimal implementation of this regimen. Issues that should be studied through operations research include acceptability, adherence, drug resistance, retention, safety, and funding. EGPAF has been an instrumental partner in assisting the WHO and individual countries to implement past guidelines, and will continue to assist as new guidelines are updated.

m2m will support country efforts to implement Option B+ by using its simple and effective Mentor Mother model to promote enrollment and retention in care. Because m2m’s Mentor Mothers provide additional human resources – educating and supporting mothers as they learn to understand, accept, and adhere to lifelong treatment regimens – they can further ease the pressure this new protocol might cause already strained health systems. m2m is prepared to use its trusted presence in communities to ensure that all women, especially those not currently accessing care, are able to benefit from Option B+.

As organizations working to implement the Global Plan towards the Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive, we are committed to overcoming any obstacle that prevents us from reaching our goal of ending HIV/AIDS in children and mothers.

There are still large numbers of HIV-positive, pregnant women who cannot access any effective PMTCT services, and so we must ensure that countries are able to accelerate efforts toward universal coverage.

We must also adequately address implementation barriers, such as weak health systems – especially in more rural settings – lack of human resources for health, and a need for significant education and community-based support to promote adherence to lifetime therapy and long-term retention in the health system.

We look forward to supporting countries to overcome these issues as they work toward achieving an AIDS-free generation.

###

 About the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF):  The Foundation is a global leader in the fight against pediatric HIV/AIDS, reaching more than 14 million women with services to prevent transmission of HIV to their babies. It currently works at more than 5,400 sites and in 15 countries to implement prevention, care, and treatment services; to advance innovative research; and to execute global advocacy activities in order to bring dramatic change to the lives of millions of women, children, and families worldwide. For more information, visit www.pedaids.org. For live updates and resources from EGPAF at the XIX International AIDS Conference, visit www.EGPAF-IAS.org, and follow us @EGPAF.

About mothers2mothers (m2m):  mothers2mothers (m2m) is eliminating transmission of HIV from mothers to babies and sustaining the health of women and children with its proven Mentor Mother model. Since its inception, m2m has reached more than one million mothers in nine countries. Founded in Cape Town in 2001, m2m is a partner in the United Nations’ Global Plan towards the Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive. Learn more at m2m.org or follow mothers2mothers @m2mtweets.

Contacts:

Michelle Milford Morse, mothers2mothers; Phone: 323-969-0445; us@m2m.org

Robert Yule, Elizabeth Glaser Pediatric AIDS Foundation; Mobile: 202-390-9540; ryule@pedaids.org

Leave a Comment

Filed under Community, EGPAF, Global Plan, IAC 2012, Implementation, Pediatric Treatment, PMTCT, Research

Upcoming EGPAF Session: Overcoming Barriers to Implementing Global Plan

By Robert Yule

Join EGPAF, mothers2mothers, Johnson & Johnson, and our other partners at this upcoming session on overcoming implementation barriers to the Global Plan.

This fast-paced session – moderated by Global Post’s John Donnelly – will feature people working on the front lines of program implementation from high-burden countries and representing various implementing organizations. Each presenter will raise a specific challenge, explain how it was addressed, describe the result, and share what is being done next.

The audience will have the opportunity to interact with presenters for further discussion of implementation barriers and solutions.

“Eliminating Pediatric AIDS and Keeping Mothers Alive from an Implementation Perspective – Best Practices, Programmatic Barriers, and Bottlenecks in the Field”
Sunday, July 22, 1:30 – 3:30 PM
Mini Room 1

Leave a Comment

Filed under Global Plan, Implementation, India, Kenya, Lesotho, Malawi, PMTCT, Rwanda, South Africa, Swaziland, Tanzania, Zambia, Zimbabwe

EGPAF’s Statement on UNAIDS Report on HIV/AIDS

By Robert Yule

Today UNAIDS released a new report on the global AIDS epidemic. Read the Foundation’s statement about the progress made preventing and treating new HIV infections in children and their mothers worldwide, and areas of continued need.

Also see below for ten useful facts and statistics taken from UNAIDS’ Global Plan progress report:

Washington, D.C. – On the eve of the XIX International AIDS Conference in Washington, D.C., a new report released by UNAIDS shows significant progress in the battle against pediatric HIV and AIDS. It also highlights some key areas of improvement needed to reach our goal of ending new HIV infections in children and keeping HIV-positive mothers and children alive and healthy.

According to UNAIDS, about 330,000 children were newly infected with HIV in 2011 – a drop of 60,000 from the previous year. Particularly promising was a reported 25% decrease in new pediatric infections since 2009 among the 21 countries in sub-Saharan Africa identified as high priority by the Global Plan to end HIV among children.
“The significant decrease in new pediatric infections in sub-Saharan Africa is clear evidence that global efforts are turning the tide of the epidemic in children in the part of the world where it is needed most,” said Chip Lyons, President and CEO of the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF).
The report also predicts that several countries where EGPAF works – such as Kenya, Swaziland, Zambia, and Zimbabwe – are on track to meet the ambitious 2015 target to eliminate new pediatric HIV infections.
Key to achieving this for all countries is universal access to services to prevent mother-to-child transmission of HIV (PMTCT). The report shows that investments in scaling up PMTCT are bearing fruit. For HIV-positive women living in low- and middle-income countries, PMTCT access has increased significantly – from 48% of in 2010, to 57% in 2011.
“One point of particular concern is that a relatively low percentage of mothers are receiving PMTCT drug regimens in the breastfeeding period, the time in which a significant amount of transmission to infants occurs,” said Lyons. “Too few mothers are also receiving antiretroviral treatment for their own health, which is vital to their survival and for the care of their children.”
For those children living with HIV, testing and treatment remains critical. According to UNAIDS, only 28% of HIV-positive children received antiretroviral treatment in 2011. While this is a slight increase from the previous year, it is still woefully inadequate. Without early identification and treatment, half of children with HIV do not survive to see their fifth birthday.
“As the global health community gathers in Washington for the AIDS 2012 conference, this report shows us where more work is needed, but also where momentum is on our side,” said Lyons. “It should encourage us to rededicate our efforts and our resources to even greater decreases in HIV infections and AIDS-related deaths in children, and to not let up until we get to zero.”
###

Leave a Comment

Filed under Pediatric Treatment, PMTCT, UNAIDS